Neurobiologia clinica

Condividi su

Gruppo guidato da Marco Capobianco

Neurobiologia clinica
Marco Capobianco

Marco Capobianco

Acting Director of the Neurology Department and Regional Referral Multiple Sclerosis Centre, S. Luigi Gonzaga Hospital

Contacts:
Tel. + 39 011 9026 697
Fax: +39 011 9026 397
mail: mcapobianco1972@gmail.com

Born in Turin (Italy), 1972 sep 19th

Education/training
Degree in Medicine and Surgery, obtained at the University of Turin on 1997 jul 17th;
Specialization in Neurology, obtained at the University of Turin on 2002 oct 10th;
Master degree in Management of Clinical Department, obtained at the e-Campus University of Novedrate (CO) on 2016 sep 29th

Present Position
Acting Director of the Neurology Department and Regional Referral Multiple Sclerosis Centre at S. Luigi Gonzaga University Hospital in Orbassano

CAREER TITLES
from 20.10.2004 to 29.11.2004 Outpatient Neurology Specialist at ASL TO8 Distretto di Chieri
from 01.12.2004 to 07.01.2006 Consultant neurologist at AOU San Luigi Gonzaga of Orbassano;
from 03.07.2007 full-time neurologist at Department of Neurology at AOU San Luigi Gonzaga of Orbassano, with the following management positions:
from 03.07.2007 to 14.06.2012 Primary assignment of band "D";
from 15.06.2012 to 31.01.2013 Primary assignment of "D" range;
from 01.02.2013 to 31.01.2016 Appointment of medium-level technical-professional skills of the "C2" category entitled "Activities of Day Hospital and Day Service";
from 01.02.2016 to 28.03.2017 Assignment of medium-level technical-professional skills of the "C2" category entitled "Activities of Day Hospital and Day Service";
from 29.03.2017 to 31.01.2018 High-level technical-professional assignment of the "C1" category entitled "Head of Day Hospital and Day Service"
from 01.02.2018 to 14.01.2020 High-level technical-professional competence assignment "C1S" entitled "Clinical Management of the Regional Referral Center for Multiple Sclerosis (CRESM) and clinical management of other autoimmune diseases of the nervous system"
from 15.01.2020 to 01.04.2021 High-level technical professional competence assignment “C” entitled “Clinical and management responsibility of the Regional Referral Multiple Sclerosis Centre (CRESM)
From 01.04.2021 director of the Neurology Department and Regional Referral Multiple Sclerosis Centre

CLINICAL-ASSISTANCE ACTIVITY
Dr. Capobianco has performed clinical-assistance activities within the Neurological Department of the San Luigi University hospital acquiring competence in the management of common neurological diseases.

In particular, he takes part in all outpatient clinical assistance, ordinary hospitalization, Day Service / Day Hospital and first aid. In this context he has acquired expertise in the management of acute neurological diseases and in particular stroke with access to systemic thrombolysis, status of epileptic disease, inflammatoryinfectious neurological pathology.
In the field of outpatient care and Day Hospital, he performs clinical-therapeutic activities with management of all immunomodulatory and immunosuppressive therapies for Multiple Sclerosis and autoimmune neurological diseases affecting both CNS and/or PNS.

As head of neurological day hospital and outpatient activities, he has coordinated the activity of medical personnel (2 units) and nurses (6 units).
He is now the director of the Neurological Department with inpatients ward (15 beds) and outpatients clinic.
He is the referent neurologist for the hospital project on the intra-hospital emergency commission.
He is the referent neurologist for the Bone Marrow Transplant Center of the San Luigi Gonzaga University Hospital.

RESEARCH ACTIVITY
Dr. Capobianco is the author of more than 80 reviewed scientific articles and more than 300 abstracts at scientific conferences.

He has also played the role of referee for several peer-reviewed scientific journals in the neurological and immunological field (Neurological Science, BMJ Neurology, Frontiers in Neurology).
He is Associate Editor for BMC Neurology.
He is involved in phase III and IV clinical studies on multiple sclerosis therapies, or spontaneous research projects both as principal investigator and treating physician (40 clinical studies conducted since 2006 to date).
In this context, he has acquired management and conduct of clinical studies receiving a qualification certificate from the GCP (Good Clinical Practice) and within the framework of Multiple Sclerosis is certified for the administration of Neurostatus.
He also partecipated to several medical meeting as speaker, mainly on the topic of Multiple Sclerosis and related disorders.

Publications:

>  PubMed.gov